The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells
Open accessAbstract
Previous studies on the anticancer activity of protoberberine alkaloids against a variety of cancer cell lines were extended to human tumour HeLa and murine leukemia L1210 cell lines. An attempt was also made to investigate the relationship between the cytotoxic activity of berberine and its molecular mechanism of action. Cytotoxicity was measured in-vitro using a primary biochemical screening according to Oyama and Eagle, and the growth inhibition assay. The in-vitro cytotoxic techniques were complemented by cell cycle analysis and determination of apoptotic DNA fragmentation in L1210 cells. Berberine acted cytotoxically on both tumour cell lines. The sensitivity of leukemia L1210 cells to the berberine was higher than that of HeLa cells. The IC100 was below 100 μg mL−1 for HeLa cells and approached a 10 μ mL−1 limit for the leukemia L1210 cells. For both cell lines the IC50 was found to be less than 4 μg mL−1, a limit put forward by the National Cancer Institute (NCI) for classification of the compound as a potential anticancer drug. In L1210 cells treated with 10–50 μ mL−1 berberine, G0/G1 cell cycle arrest was observed. Futhermore, a concentration-dependent decrease of cells in S phase and increase in G2/M phase was detected. In addition, apoptosis detected as sub-G0 cell population in cell cycle measurement was proved in 25–100 μg mL−1 berberine-treated cells by monitoring the apoptotic DNA fragmentation (DNA ladder) using agarose gel electrophoresis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
St-Onge, M.-P., Farnworth, E. R., Savard, T., Chabot, D., Mafu, A., & Jones, P. J. (2002) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-2-1 · Cited by 167
Lin, H.-L., Liu, T.-Y., Wu, C.-W., & Chi, C.-W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690710 · Cited by 100
Research works printed but not linked: 35
- Amin, 1969, Berberine sulphate: antimicrobial activity, bioassay, and mode of action, Can. J. Microbiol., 15, 1067, 10.1139/m69-190 · DOI · Paper page
- Anis, 1999, Role of berberine as an adjuvant response modifier during tumour therapy in mice, Pharm. Pharmacol. Commun., 5, 697, 10.1211/146080899128734415 · DOI
- Anis, 2001, Inhibition of chemical carcinogenesis by berberine in rats and mice, J. Pharm. Pharmacol., 53, 763, 10.1211/0022357011775901 · DOI · Paper page
- Ĉern̂áková, 2002, Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium, BMC Complement. Altern. Med., 2, 1, 10.1186/1472-6882-2-2 · DOI
- Chang, 1990, Berberine-induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells, Cancer Lett., 55, 103, 10.1016/0304-3835(90)90018-S · doi:10.1016/0304-3835(90)90018-s
- Chen, 1994, Effect of berberine alone or in combination with argon ion laser treatment on the 9L rat glioma cell line, Chin. Med. J. (Engl), 107, 808
- Chi, 1994, Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells, Life Sci., 54, 2099, 10.1016/0024-3205(94)00719-5 · DOI
- Dai, 1993, Studies on Indonesian plants. V. Cytotoxic constituents of the roots of the Indonesian medicinal plant Fibraurea chloroleuca, Phytotherapy Res., 7, 290, 10.1002/ptr.2650070406 · DOI
- Fakuda, 1999, Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells, J. Ethnopharmacol., 2, 227, 10.1016/S0378-8741(98)00162-7 · DOI · Paper page
- Iizuka, 2000, Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines, Cancer Lett., 148, 19, 10.1016/S0304-3835(99)00264-5 · DOI · Paper page
- Iwasa, 1997, Antimicrobial activity of some 13-alkylsubstituted protoberberinum salts, Planta Med., 63, 196, 10.1055/s-2006-957651 · DOI
- Iwasa, 2001, In vitro cytotoxicity of the protoberberine-type alkaloids, J. Nat. Prod., 64, 896, 10.1021/np000554f · DOI
- Jantová, 2003, Induction of cytotoxicity and ssDNA breaks by 9-bromo-5-morpholino-tetrazolo[1,5-c]quinazoline in tumor cells cultured in vitro, Toxicol. in Vitro., 10.1016/S0887-2333(03)00066-3 · doi:10.1016/s0887-2333(03)00066-3
- Jeon, 2002, NMR studies on antitumor drug candidates, berberine and berberrubine, Bull. Korean. Chem. Soc., 3, 391
- Kim, 2002, Design, syntheses and biological evaluations of nonpeptidic caspase 3 inhibitors, Bull. Korean. Chem. Soc., 7, 1003
- Kobayashi, 1995, Inhibitors of DNA topoisomerase I and II from Coptis rhizomes, Planta Med., 61, 414, 10.1055/s-2006-958127 · doi:10.1055/s-2006-958127
- Krishnan, 2000, The 9-position in berberine analogs is an important determinant of DNA topisomerase II inhibition, Anti-cancer Drug Design, 15, 255
- Kuo, 1995, Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells, Cancer Lett., 93, 193, 10.1016/0304-3835(95)03809-B · DOI · Paper page
- Lee, 1995, Enhanced cytotoxicity of berberine and some anticancer nucleotides against tumor cell-lines, Arch. Pharm. Res., 18, 138, 10.1007/BF02979149 · doi:10.1007/bf02979149
- Li, 2000, Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug–enzyme interactions, Biochemistry, 39, 7107, 10.1021/bi000171g · doi:10.1021/bi000171g
- Lin, 1999, Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells, Cancer, 85, 1937, 10.1002/(SICI)1097-0142(19990501)85:9<1937::AID-CNCR9>3.0.CO;2-F · doi:10.1002/(sici)1097-0142(19990501)85:9<1937::aid-cncr9>3.0.co;2-f
- Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 256, 10.1016/S0021-9258(19)52451-6 · DOI · Paper page
- Mazzini, 2003, Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide d(AAGAATTCTT)(2), Bioorg. Med. Chem., 4, 505, 10.1016/S0968-0896(02)00466-2 · doi:10.1016/s0968-0896(02)00466-2
- Miura, 1997, Inhibition of thymocyte apoptosis by berberine, Biochem. Pharmacol., 53, 1315, 10.1016/S0006-2952(97)87955-5 · doi:10.1016/s0006-2952(97)87955-5
- Okunade, 1994, Antimicrobial properties of alkaloids from Xanthoriza simplicissima, J. Pharm. Sci., 83, 404, 10.1002/jps.2600830327 · DOI
- Orfila, 2000, Structural modification of berberine in relation to cytotoxic activity in vitro, J. Ethnopharmacol., 71, 449, 10.1016/S0378-8741(00)00177-X · DOI
- Oyama, 1956, Measurement of cell growth in tissue with a phenol reagent (Folin–Ciocalteau), Proc. Soc. Exp. Biol. Med., 91, 305, 10.3181/00379727-91-22245 · DOI · Paper page
- Pisha, 1995, Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis, Nature Med., 1, 1046, 10.1038/nm1095-1046 · DOI · Paper page
- Rauko, 2001, Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine, Eur. J. Pharm. Sci., 12, 387, 10.1016/S0928-0987(00)00180-9 · doi:10.1016/s0928-0987(00)00180-9
- Ren, 1999, Sequence and structural selectivity of nucleic acid binding ligands, Biochemistry, 38, 16067, 10.1021/bi992070s · DOI · Paper page
- Sanders, 1998, Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells, Biochem. Pharmacol., 56, 1157, 10.1016/S0006-2952(98)00243-3 · doi:10.1016/s0006-2952(98)00243-3
- Sarma, 1999, Antifungal activity of berberine iodide, a constituent of Fumaria indica, Folia Microbiol., 44, 164, 10.1007/BF02816235 · DOI
- Tang, 2002, Recent development of antitumor agents from Chinese herbal medicine; Part I. Low molecular compounds, Planta Med., 69, 97, 10.1055/s-2003-37718 · DOI
- Yang, 1996, Dose dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells, Naunyn–Schmiedebergs Arch. Pharmacol., 354, 102, 10.1007/BF00178709 · DOI
- Zhang, 1990, Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors, Chin. Med. J. (Engl), 103, 658
Cited by
Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054
Zinc and human health: an update
Chasapis, C. T., Loutsidou, A. C., Spiliopoulou, C. A., & Stefanidou, M. E. (2012) · Archives of Toxicology · doi:10.1007/s00204-011-0775-1 · Cited by 1,053
Tang, J., Feng, Y., Tsao, S., Wang, N., Curtain, R., & Wang, Y. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.009 · Cited by 491
A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Sun, Y., Xun, K., Wang, Y., & Chen, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330d95b · Cited by 417
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
Metadata
- Authors
- Jantová, S., čipák, L., čerňáková, M., & Košt‘álová, D.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-01
- Volume
- 55
- Issue
- 8
- Pages
- 1143-1149
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2067706443
- Cited by
- 176
- References
- 2
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. https://app.cochat.ai/papers/10.1211/002235703322277186
- The paper
- Jantová, S., čipák, L., čerňáková, M., & Košt‘álová, D. (2003). Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/002235703322277186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.